✦ LIBER ✦

The community physician's involvement in clinical trials and home treatment

✍ Scribed by Narayan R. Shah

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 291 KB
Volume: 58
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19860715)58:2+<504::aid-cncr2820581314>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials and the community physic

Clinical trials and the community physician

✍ Arthur S. Levine 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 1 views

Clinical trials for cancer patients. The

Clinical trials for cancer patients. The community practicing physician's perspective

✍ Irvin D. Fleming 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB 👁 2 views

Clinical trials of botulinum toxin in th

Clinical trials of botulinum toxin in the treatment of spasticity

✍ David M. Simpson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Drug treatment of older people with affe

Drug treatment of older people with affective disorders in the community: lessons from an attempted clinical trial

✍ Tim Stevens; Cornelius Katona; Monica Manela; Vivienne Watkin; Gill Livingston 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Background. Depression and phobic anxiety disorders are the most common psychiatric disorders in people aged 65 and over. SSRI antidepressants are eective in treating both conditions in younger people, and in treating depression in hospital samples of older subjects. No studies have investigated the

The role of biostatistics in the prevent

The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials

✍ Marc Buyse; Stephen L. George; Stephen Evans; Nancy L. Geller; Jonas Ranstam; Br 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

Recent cases of fraud in clinical trials have attracted considerable media attention, but relatively little reaction from the biostatistical community. In this paper we argue that biostatisticians should be involved in preventing fraud (as well as unintentional errors), detecting it, and quantifying

Estimating treatment effects in randomiz

Estimating treatment effects in randomized clinical trials in the presence of non-compliance

✍ Nico Nagelkerke; Vaclav Fidler; Roos Bernsen; Martien Borgdorff 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

In clinical trials where patients are randomized between two treatment arms, not all patients comply with the treatment they were randomly assigned to. The reasons for (non)compliance may be associated with the outcome variable and thereby act as confounders. The standard way of analysing such trial